Detalles de la búsqueda
1.
Hormonal prostate cancer therapies and cardiovascular disease: a systematic review.
Heart Fail Rev
; 27(1): 119-134, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32500365
2.
Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
Int J Cancer
; 136(5): 1234-40, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25042739
3.
Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.
Int J Cancer
; 133(2): 373-82, 2013 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23319273
4.
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.
Cancer Immunol Immunother
; 60(2): 197-206, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20976449
5.
Propensity for Early Metastatic Spread in Breast Cancer: Role of Tumor Vascularization Features and Tumor Immune Infiltrate.
Cancers (Basel)
; 13(23)2021 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34885027
6.
New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.
Cancer Immunol Immunother
; 59(1): 63-71, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19495750
7.
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.
Cancer Immunol Immunother
; 59(5): 663-74, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19890632
8.
Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.
Clin Cancer Res
; 14(4): 1032-40, 2008 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18281535
9.
Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant.
Clin Cancer Res
; 14(16): 5284-91, 2008 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18698048
10.
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma.
Clin Cancer Res
; 14(10): 3060-9, 2008 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18483372
11.
[Analysis of the European Consensus on the treatment of opioid-induced constipation analgesic drugs.] / Analisi del consensus europeo sul trattamento della stipsi indotta da farmaci analgesici oppiacei.
Recenti Prog Med
; 110(7): 338-342, 2019.
Artículo
en Italiano
| MEDLINE | ID: mdl-31379368
12.
Issues and promises of bevacizumab in prostate cancer treatment.
Expert Opin Biol Ther
; 18(6): 707-717, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29781343
13.
Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
Int J Oncol
; 30(2): 381-92, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17203220
14.
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.
Cancer Biomark
; 17(3): 335-345, 2016 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27434293
15.
The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy.
Oncoimmunology
; 5(7): e1188243, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27622042
16.
Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.
Expert Opin Investig Drugs
; 24(7): 929-47, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25858813
17.
Immune reaction and colorectal cancer: friends or foes?
World J Gastroenterol
; 20(35): 12407-19, 2014 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25253941
18.
Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches.
Expert Opin Investig Drugs
; 23(4): 469-87, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24490883
19.
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients.
Med Oncol
; 31(9): 166, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25148896
20.
Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer.
Rejuvenation Res
; 16(3): 224-31, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23521603